tiprankstipranks
Advertisement
Advertisement
Emergent BioSolutions price target lowered to $12 from $15 at H.C. Wainwright
PremiumThe FlyEmergent BioSolutions price target lowered to $12 from $15 at H.C. Wainwright
2M ago
Emergent BioSolutions Adds Independent Director Amid Turnaround Efforts
Premium
Company Announcements
Emergent BioSolutions Adds Independent Director Amid Turnaround Efforts
2M ago
Emergent BioSolutions appoints Fowler to board of directors
Premium
The Fly
Emergent BioSolutions appoints Fowler to board of directors
2M ago
Emergent BioSolutions announces up to C$140M in Canadian contracts
PremiumThe FlyEmergent BioSolutions announces up to C$140M in Canadian contracts
2M ago
Emergent BioSolutions authorizes $50M stock repurchase program
Premium
The Fly
Emergent BioSolutions authorizes $50M stock repurchase program
2M ago
Emergent BioSolutions Reports Profitability Amid Ongoing Turnaround
Premium
Company Announcements
Emergent BioSolutions Reports Profitability Amid Ongoing Turnaround
2M ago
Emergent announces U.S. FDA approved sNDA for OTC NARCAN nasal spray
PremiumThe FlyEmergent announces U.S. FDA approved sNDA for OTC NARCAN nasal spray
3M ago
Emergent BioSolutions Advances Turnaround With Major Debt Prepayment
Premium
Company Announcements
Emergent BioSolutions Advances Turnaround With Major Debt Prepayment
3M ago
Emergent BioSolutions announces $100M paydown of term loan principal
Premium
The Fly
Emergent BioSolutions announces $100M paydown of term loan principal
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100